Login / Signup

Effects of combined treatment with fesoterodine and mirabegron in a pelvic congestion rat model: Results from in vitro and in vivo functional studies.

Kimio SugayaHidetomi YamagamiSaori NishijimaKatsumi KadekawaMasanori HizueYoshihiko ItoShizuo Yamada
Published in: Lower urinary tract symptoms (2019)
The combination of 5-hydroxymethyl tolterodine with mirabegron suggests the potential of synergistic effects in a rat pelvic congestion model.
Keyphrases
  • rectal cancer
  • oxidative stress
  • case control
  • combination therapy
  • drug delivery
  • replacement therapy